Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors

Laurien A Daniëls1, Stijn D G Krol1, Michiel A de Graaf2

  • 1Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Insights

Cardiovascular disease screening in Hodgkin lymphoma survivors is well-received, improving patient understanding of risks and benefits. Counseling enhances satisfaction, outweighing any emotional burden from screening.

Area of Science:

  • Cardiology
  • Oncology
  • Health Outcomes Research

Background:

  • Cardiovascular disease (CVD) is a leading cause of non-cancer death in Hodgkin lymphoma (HL) survivors, particularly those treated with mediastinal irradiation.
  • The benefits and burdens of CVD screening in this population remain unclear, with potential impacts on health-related quality of life (HRQL).

Purpose of the Study:

  • To evaluate the HRQL, emotional and practical burden, and perceived benefits of CVD screening using computed tomography angiography (CTA) in HL survivors.
  • To assess the effect of CVD-specific counseling on patient satisfaction and information provision.

Main Methods:

  • A phase 2 screening study involving HL survivors who underwent CTA.
  • HRQL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire C30.
  • Information provision and satisfaction were evaluated using the EORTC INFO-25 questionnaire, with assessments at baseline and post-screening.

Main Results:

  • Most participants (93%) were content with screening, and 80% found the focus on late effects not burdensome.
  • Screening had a minor impact on social functioning and global quality of life.
  • Significant improvements in perceived information about disease, tests, and treatment were observed post-screening (P<.01).

Conclusions:

  • CVD screening via CTA was viewed favorably by HL survivors, irrespective of detected abnormalities.
  • Extensive counseling significantly enhanced information provision and satisfaction.
  • The perceived benefits of screening and subsequent cardiac intervention outweighed the emotional and practical burdens.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
887
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
611